Carl E. Orringer, MD, FACC, FNLA is a Professor of Medicine at the University of Miami Miller School of Medicine, Miami, Florida and Director of the Preventive Cardiovascular Medicine Program for the University of Miami Health System. He was the first recipient of the Harrington Chair in Preventive Cardiovascular Medicine at University Hospitals Case Medical Center in Cleveland, Ohio. He is a past president and fellow of the National Lipid Association. He has served as Editor-in-Chief of three editions of the National Lipid Association Self-Assessment Program and is the author of the Lipid Management section of the American College of Cardiology Self Assessment Program through 2023. He is a fellow of the American College of Cardiology and is a co-author of American College of Cardiology Expert Consensus Decision Pathway documents on the Management of Hypertriglyceridemia in 2021 and on Non-Statin Therapies in 2022. He served as a member of Writing Committee of the 2018 American Heart Association/ACC/Multi-Society Guideline on the Treatment of Blood Cholesterol and has authored or co-authored multiple National Lipid Association Scientific Statements. He is an Associate Editor of the European Heart Journal.


Targets and goals - The NLA way